Stock Quotes/News
e.g. "CSCO". Quotes delay times are 15 mins for NASDAQ, 20 mins for NYSE and Amex.
Bioject Medical Technologies Inc.
(Public, OTC:BJCT) Watch this stockFind more results for
BJCT
Advertisement
Events
Aug 16, 2010
Q2 2010 Earnings Release
Jul 10, 2010
Annual Shareholders Meeting
Key stats and ratios
Q2 (Jun '10)
2009
Net profit margin
-48.05%
-16.13%
Operating margin
-51.28%
-13.21%
EBITD margin
-
-4.00%
Return on average assets
-52.73%
-19.53%
Return on average equity
-
-
Employees
32
-
Carbon Disclosure Rating
-
-
Address
Website links
External links
Discussion Group - Google Finance
Description
Bioject Medical Technologies Inc. is a developer and manufacturer of needle-free injection therapy systems (NFITS). The NFITS work by forcing liquid medication at high speed through a tiny orifice held against the skin. It creates a fine stream of high-pressure medication, which penetrates the skin, depositing the medication in the tissue beneath. The products of the Company include Biojector 2000, Drug Reconstitution System, Vitajet and ZetaJet.
Google Finance
Bioject Medical Q2 net loss widens
Trading Markets - Aug 9, 2010
Trading Markets - Aug 9, 2010
Bioject Medical Technologies, a developer of needle-free injection therapy systems, has reported that net loss for the second quarter ended June 30, 2010 was $556,000, or $0.03 per share, compared ...
Bioject Reports Second Quarter 2010 Financial Results
Business Wire - Aug 4, 2010
Business Wire - Aug 4, 2010
PORTLAND, Ore.--(BUSINESS WIRE)--Bioject Medical Technologies Inc. (OTCBB:BJCT), a leading developer of needle-free drug delivery systems, today reported financial results for the second quarter ...
Bioject reports earnings, sales declines - Portland Business Journal
Bioject to Report Second Quarter 2010 Financial Results
Business Wire - Jul 29, 2010
Business Wire - Jul 29, 2010
PORTLAND, Ore.--(BUSINESS WIRE)--Bioject Medical Technologies Inc. (OTCBB: BJCT), a leading developer of needle-free injection therapy systems, announced today that the Company will report its ...
The World's Largest Communications And Technology Community
TMCnet.com - Jul 16, 2010
TMCnet.com - Jul 16, 2010
A recent study in The New England Journal of Medicine showed that fractional doses of inactivated poliovirus vaccine could be given to infants safely and effectively by intradermal administration ...
Bioject Delivers Infant Vaccines Via Needle-Free Injection
TMC Net - Jul 16, 2010
TMC Net - Jul 16, 2010
A recent study in The New England Journal of Medicine showed that fractional doses of inactivated poliovirus vaccine could be given to infants safely and effectively by intradermal administration ...
Bioject's Intradermal Needle-Free Delivery System Deployed in World Health Organization Clinical Trial in Oman
Trading Markets - Jul 13, 2010
Trading Markets - Jul 13, 2010
Bioject Medical Technologies Inc., a developer of needle-free injection therapy systems, said that Bioject's needle-free injection delivery technology was used to successfully demonstrate that ...
OTC ADVISORS, LLC: Huge Alert On: (OTCBB:BJCT) - (OTCBB:ADLS) - (OTCBB:FCSC)
Trading Markets - Jul 8, 2010
Trading Markets - Jul 8, 2010
www.otc-advisors.com names (OTCBB: BJCT | PowerRating)Bioject Medical Technologies Inc. (OTCBB: ADLS | PowerRating) Advanced Life Sciences Holdings, Inc. and (OTCBB: FCSC | PowerRating) Fibrocell ...
Bioject’s Intradermal Needle-Free Delivery System Used in World Health Organization Clinical Trial in Oman with Poliovirus Vaccine
Business Wire - Jul 8, 2010
Bioject’s Intradermal Needle-Free Delivery System Used in World Health Organization Clinical Trial in Oman with Poliovirus Vaccine - Bradenton Herald
Business Wire - Jul 8, 2010
PORTLAND, Ore.--(BUSINESS WIRE)--Bioject Medical Technologies Inc. (OTCBB: BJCT), a leading developer of needle-free injection therapy systems, today announced that Bioject's needle-free injection ...
ShamrockStocks.com: Lucky Picks of The Day: (OTCBB:NXTH)- (OTCBB:BJCT)- (OTCBB:VSYM) - Trading MarketsBioject’s Intradermal Needle-Free Delivery System Used in World Health Organization Clinical Trial in Oman with Poliovirus Vaccine - Bradenton Herald
Bacterin International Hires Seasoned Financial Healthcare Professional as its Chief Financial Officer
PR Newswire - Jun 8, 2010
PR Newswire - Jun 8, 2010
BELGRADE, Mont., June 8 /PRNewswire/ -- Bacterin International, Inc. (Bacterin), a developer of anti-infective coatings for medical applications and revolutionary bone graft material, today ...
Bioject Medical Technologies Inc. Annual Shareholder Meeting Thursday, June 10, 2010
Business Wire - Jun 2, 2010
Business Wire - Jun 2, 2010
PORTLAND, Ore.--(BUSINESS WIRE)--Bioject Medical Technologies Inc., (OTCBB:BJCT), a leading developer of needle-free injection therapy systems, announced today that the Company will hold its ...
BIOJECT MED: Bioject Medical Technologies Inc. Annual Shareholder Meeting Thurs.. - 4-traders
Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. Quotes are delayed 15 minutes for Nasdaq, 20 minutes for AMEX and NYSE.